Digital Care for holistic health in older adults with diabetes and multiple conditions
Official title: Digital Care Community Common Good Program Enhances Holistic Health Management for Middle Aged and Older Adults With Diabetes Mellitus and Multiple Chronic Conditions
Run by Chang Gung University of Science and Technology · NCT07310849 · Data updated 2026-11-12
This study tests a digital care program to help adults 50+ with type 2 diabetes and other chronic diseases improve disease control, self-management, mood, and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 169 (estimated) |
| Sponsor | Chang Gung University of Science and Technology Academic / other |
| Locations | 1 site (New Taipei City, Wugu District) |
| Status | Recruiting |
| Started | May 12, 2026 |
| Main results expected | June 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07310849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 50 years or older with type 2 diabetes and at least one coexisting chronic condition, who own a smartphone, can use LINE, and reside in one of the four participating communities.
✕Probably not a fit
Participants with severe diabetes-related complications or certain psychiatric or cancer-related conditions may not experience benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study in New Taipei City assesses the Digital Care Community Common Good program against usual care. Over two years, researchers will build an integrated care team, expand an mHealth platform, create digital education for diabetes with comorbidities, and train community volunteers. About 169 eligible participants aged 50 and older with type 2 diabetes and at least one other chronic condition will be recruited from four communities and randomized to receive the digital program or usual care. The second year will include a 6-month intervention with effectiveness evaluation of the program's impact on disease control, self-management, depression, and quality of life. The study emphasizes community resources, smartphone-based tools, and LINE messaging to support participants in Mandarin or Taiwanese.
Why it matters
Potential benefit: If successful, participants could experience better diabetes and comorbidity control, improved self-management, and higher quality of life.
How similar studies have gone: Previous digital-health and community-embedded programs have shown improvements in self-management and quality of life, though this exact combination in older adults with multimorbidity is being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age and Consent: Individuals aged 50 years or older who are willing to provide written informed consent. * Language and Literacy: Participants must be literate and able to communicate in Mandarin or Taiwanese. * Medical Diagnosis: Participants must have a physician-confirmed diagnosis of type 2 diabetes mellitus (T2DM) and at least one comorbid chronic disease (e.g., hypertension, hyperlipidemia, chronic kidney disease, or heart disease). * Technology Use: Participants must own a smartphone and be willing to use the LINE messaging app and web-based health education links. * Residence: Participants must reside within one of the four participating communities and have no plans to move away during the study intervention period. Exclusion Criteria: * Those with severe diabetes-related complications, such as renal failure, cerebrovascular disease, diabetic foot, or retinopathy. * Individuals with psychiatric disorders, undergoing active cancer treatment, or those unable to perform independent self-care (e.g., due to visual impairment or mobility limitations). * Individuals without diabetes but with other chronic diseases. * Individuals residing in long-term care institutions. * Individuals who are simultaneously participating in other intervention programs.
Where it's running
-
Wugu District Public Health Center,
New Taipei City, Wugu District, Taiwan Recruiting
Study contacts
- Study coordinator: Fei-Ling Wu
- Email: flwu@mail.cgust.edu.tw
- Phone: +886-918279618
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-drug interaction study of UIC202601 and UIC202602 in healthy adults
This study tests whether combining two investigational drugs changes how they behave in the body and whether the combination is safe in healthy volunteers.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
-
Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol
This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.
-
Structured management of adult cardiovascular risk factors in outpatient care
This project will try a structured clinic approach to managing blood pressure, cholesterol, diabetes, and weight in adults with cardiovascular risk factors to see if it improves risk control and outcomes.
-
Digital tool for doctors to prescribe exercise for people with cardiovascular risk factors
This project will test whether a new digital tool helps doctors create personalized exercise plans for adults with cardiovascular risk factors.
-
Personalized daily step targets to change body fat and cardiometabolic risk in adults with overweight or obesity
This project will test if giving personalized daily step targets based on body fat helps adults with overweight or obesity change body composition and lower cardiometabolic risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.